Try the Demo today!
| SEC Filing | Insider | Company | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Return |
|---|---|---|---|---|---|---|---|---|---|
| 20-Sep-24 4:39 PM View:  | Linetsky David SVP, Life Sciences | Phreesia, Inc. (PHR) | 19-Sep-24 | Sale | 24 | $24.04 | $577.04 | (< 1%) 212.31K to 212.29K | |
| 19-Sep-24 5:49 PM View: | Linetsky David SVP, Life Sciences | Phreesia, Inc. (PHR) | 18-Sep-24 | Sale | 61 | $24.09 | $1,469.28 | (< 1%) 212.37K to 212.31K | |
| 19-Sep-24 5:49 PM View: | Linetsky David SVP, Life Sciences | Phreesia, Inc. (PHR) | 17-Sep-24 | Sale | 36 | $24.77 | $891.54 | (< 1%) 212.41K to 212.37K | |
| 13-Sep-24 4:06 PM View: | Egbuonu-Davis Lisa Director | Phreesia, Inc. (PHR) | 12-Sep-24 | Sale | 1,400 | $23.03 | $32,239.20 | (7%) 19.54K to 18.14K | |
| 12-Sep-24 5:51 PM View: | Hoffman Allison C General Counsel & Secretary | Phreesia, Inc. (PHR) | 11-Sep-24 | Sale (Planned) | 2,072 | $23.36 | $48,401.90 | (2%) 123.08K to 121.0K | |
| 12-Sep-24 6:02 PM View: | Hui Yvonne Principal Accounting Officer | Phreesia, Inc. (PHR) | 10-Sep-24 | Sale | 744 | $23.25 | $17,298.10 | (2%) 30.76K to 30.02K | |
| 12-Sep-24 6:03 PM View: | Gandhi Balaji Chief Financial Officer | Phreesia, Inc. (PHR) | 10-Sep-24 | Sale | 3,502 | $23.25 | $81,422.20 | (3%) 102.08K to 98.58K | |
| 12-Sep-24 5:53 PM View: | Vanduyn Amy Beth SVP, Human Resources | Phreesia, Inc. (PHR) | 10-Sep-24 | Sale | 737 | $23.25 | $17,135.40 | (< 1%) 120.28K to 119.54K | |
| 12-Sep-24 6:00 PM View: | Indig Chaim Chief Executive Officer Director | Phreesia, Inc. (PHR) | 10-Sep-24 | Sale | 5,295 | $23.25 | $123,110.00 | (< 1%) 1.48M to 1.48M | |
| 12-Sep-24 5:58 PM View: | Linetsky David SVP, Life Sciences | Phreesia, Inc. (PHR) | 10-Sep-24 | Sale | 1,716 | $23.25 | $39,897.30 | (< 1%) 214.22K to 212.5K | |
| 12-Sep-24 5:51 PM View: | Hoffman Allison C General Counsel & Secretary | Phreesia, Inc. (PHR) | 10-Sep-24 | Sale | 2,622 | $23.25 | $60,962.00 | (2%) 125.7K to 123.08K | |
| 12-Sep-24 5:55 PM View: | Roberts Evan Chief Operating Officer | Phreesia, Inc. (PHR) | 10-Sep-24 | Sale | 3,148 | $23.25 | $73,191.60 | (< 1%) 758.87K to 755.72K | |
| 12-Sep-24 5:58 PM View: | Linetsky David SVP, Life Sciences | Phreesia, Inc. (PHR) | 10-Sep-24 | Sale | 95 | $23.25 | $2,208.77 | (< 1%) 212.5K to 212.41K | |
| 10-Sep-24 4:56 PM View: | Linetsky David SVP, Life Sciences | Phreesia, Inc. (PHR) | 06-Sep-24 | Grant | 2,816 | -- | -- | 1% 211.17K to 213.99K | |
| 10-Sep-24 5:07 PM View: | Hoffman Allison C General Counsel & Secretary | Phreesia, Inc. (PHR) | 06-Sep-24 | Grant | 4,694 | -- | -- | 4% 121.0K to 125.7K | |
| 10-Sep-24 5:09 PM View: | Gandhi Balaji Chief Financial Officer | Phreesia, Inc. (PHR) | 06-Sep-24 | Grant | 5,633 | -- | -- | 6% 96.45K to 102.08K | |
| 10-Sep-24 4:56 PM View: | Linetsky David SVP, Life Sciences | Phreesia, Inc. (PHR) | 06-Sep-24 | Grant | 234 | -- | -- | < 1% 213.99K to 214.22K | |
| 28-Aug-24 4:57 PM View: | Hoffman Allison C General Counsel & Secretary | Phreesia, Inc. (PHR) | 26-Aug-24 | Sale | 14,110 | $26.03 | $367,241.00 | (10%) 135.11K to 121.0K | |
| 16-Aug-24 4:05 PM View: | Linetsky David SVP, Life Sciences | Phreesia, Inc. (PHR) | 15-Aug-24 | Grant | 2,000 | -- | -- | < 1% 209.17K to 211.17K | |
| 01-Aug-24 5:33 PM View: | Cahill Edward L Director | Phreesia, Inc. (PHR) | 31-Jul-24 | Grant | 400 | $24.95 | $9,980.00 | < 1% 46.09K to 46.49K | |
| 01-Aug-24 5:25 PM View: | Munson Gillian Director | Phreesia, Inc. (PHR) | 31-Jul-24 | Grant | 400 | $24.95 | $9,980.00 | 1% 35.78K to 36.18K | |
| 01-Aug-24 5:30 PM View: | Goldstein Lainie Director | Phreesia, Inc. (PHR) | 31-Jul-24 | Grant | 400 | $24.95 | $9,980.00 | < 1% 40.16K to 40.56K | |
| 30-Jul-24 5:05 PM View: | Indig Chaim Chief Executive Officer Director | Phreesia, Inc. (PHR) | 29-Jul-24 | Option Exercise | 7 | $2.03 | $14.21 | < 1% 1.47M to 1.47M | |
| 30-Jul-24 5:05 PM View: | Indig Chaim Chief Executive Officer Director | Phreesia, Inc. (PHR) | 29-Jul-24 | Planned Option Sale | 7 | $24.75 | $173.25 | (< 1%) 1.47M to 1.47M | |
| 22-Jul-24 4:56 PM View: | Smith Mark Douglas Director | Phreesia, Inc. (PHR) | 18-Jul-24 | Planned Option Sale | 7,000 | $25.00 | $175,000.00 | (19%) 37.65K to 30.65K | |
| 22-Jul-24 4:56 PM View: | Smith Mark Douglas Director | Phreesia, Inc. (PHR) | 18-Jul-24 | Option Exercise | 7,000 | $4.71 | $32,970.00 | 23% 30.65K to 37.65K | |
| 17-Jul-24 5:24 PM View: | Roberts Evan Chief Operating Officer | Phreesia, Inc. (PHR) | 16-Jul-24 | Sale | 1,669 | $23.74 | $39,614.70 | (< 1%) 754.9K to 753.23K | |
| 17-Jul-24 5:28 PM View: | Hoffman Allison C General Counsel & Secretary | Phreesia, Inc. (PHR) | 16-Jul-24 | Sale | 800 | $23.74 | $18,988.50 | (< 1%) 135.91K to 135.11K | |
| 17-Jul-24 5:27 PM View: | Gandhi Balaji Chief Financial Officer | Phreesia, Inc. (PHR) | 16-Jul-24 | Sale | 783 | $23.74 | $18,585.00 | (< 1%) 97.23K to 96.45K | |
| 17-Jul-24 5:30 PM View: | Indig Chaim Chief Executive Officer Director | Phreesia, Inc. (PHR) | 16-Jul-24 | Sale | 2,644 | $23.74 | $62,756.90 | (< 1%) 1.48M to 1.47M | |
| 17-Jul-24 5:29 PM View: | Hui Yvonne Principal Accounting Officer | Phreesia, Inc. (PHR) | 16-Jul-24 | Sale | 283 | $23.74 | $6,717.17 | (< 1%) 29.0K to 28.71K | |
| 17-Jul-24 5:31 PM View: | Linetsky David SVP, Life Sciences | Phreesia, Inc. (PHR) | 16-Jul-24 | Sale | 1,820 | $23.74 | $43,198.80 | (< 1%) 210.99K to 209.17K | |
| 17-Jul-24 5:26 PM View: | Vanduyn Amy Beth SVP, Human Resources | Phreesia, Inc. (PHR) | 16-Jul-24 | Sale | 374 | $23.74 | $8,877.11 | (< 1%) 119.01K to 118.64K | |
| 17-Jul-24 5:29 PM View: | Hui Yvonne Principal Accounting Officer | Phreesia, Inc. (PHR) | 15-Jul-24 | Grant | 13,000 | $22.82 | $296,660.00 | 81% 16.0K to 29.0K | |
| 28-Jun-24 5:08 PM View: | Munson Gillian Director | Phreesia, Inc. (PHR) | 26-Jun-24 | Grant | 8,490 | -- | -- | 31% 27.29K to 35.78K | |
| 28-Jun-24 5:09 PM View: | Goldstein Lainie Director | Phreesia, Inc. (PHR) | 26-Jun-24 | Grant | 8,490 | -- | -- | 27% 31.67K to 40.16K | |
| 28-Jun-24 5:20 PM View: | Weintraub Michael Director | Phreesia, Inc. (PHR) | 26-Jun-24 | Grant | 8,490 | -- | -- | 3% 332.08K to 340.57K | |
| 28-Jun-24 5:04 PM View: | Smith Mark Douglas Director | Phreesia, Inc. (PHR) | 26-Jun-24 | Grant | 8,490 | -- | -- | 38% 22.16K to 30.65K | |
| 28-Jun-24 5:11 PM View: | Egbuonu-Davis Lisa Director | Phreesia, Inc. (PHR) | 26-Jun-24 | Grant | 8,490 | -- | -- | 77% 11.05K to 19.54K | |
| 28-Jun-24 5:17 PM View: | Cahill Edward L Director | Phreesia, Inc. (PHR) | 26-Jun-24 | Grant | 8,490 | -- | -- | 18% 46.09K to 54.58K | |
| 28-Jun-24 5:06 PM View: | Sayar Ramin Director | Phreesia, Inc. (PHR) | 26-Jun-24 | Grant | 8,490 | -- | -- | 47% 18.25K to 26.73K | |
| 24-Jun-24 4:29 PM View: | Linetsky David SVP, Life Sciences | Phreesia, Inc. (PHR) | 21-Jun-24 | Sale | 27 | $20.24 | $546.39 | (< 1%) 211.02K to 210.99K | |
| 24-Jun-24 4:30 PM View: | Gunzburg Janet Principal Accounting Officer | Phreesia, Inc. (PHR) | 21-Jun-24 | Sale | 114 | $20.24 | $2,306.96 | (< 1%) 34.93K to 34.82K | |
| 21-Jun-24 4:35 PM View: | Linetsky David SVP, Life Sciences | Phreesia, Inc. (PHR) | 20-Jun-24 | Sale | 66 | $19.73 | $1,302.33 | (< 1%) 211.08K to 211.02K | |
| 21-Jun-24 4:35 PM View: | Linetsky David SVP, Life Sciences | Phreesia, Inc. (PHR) | 18-Jun-24 | Sale | 41 | $19.20 | $787.08 | (< 1%) 211.13K to 211.08K | |
| 02-May-24 4:22 PM View: | Gunzburg Janet Principal Accounting Officer | Phreesia, Inc. (PHR) | 01-May-24 | Sale | 286 | $21.00 | $6,005.63 | (< 1%) 35.22K to 34.93K | |
| 02-May-24 4:21 PM View: | Goldstein Lainie Director | Phreesia, Inc. (PHR) | 30-Apr-24 | Grant | 482 | $20.74 | $9,996.68 | 2% 31.19K to 31.67K | |
| 02-May-24 4:21 PM View: | Cahill Edward L Director | Phreesia, Inc. (PHR) | 30-Apr-24 | Grant | 482 | $20.74 | $9,996.68 | 1% 45.6K to 46.09K | |
| 02-May-24 4:21 PM View: | Munson Gillian Director | Phreesia, Inc. (PHR) | 30-Apr-24 | Grant | 482 | $20.74 | $9,996.68 | 2% 26.8K to 27.29K | |
| 19-Apr-24 4:24 PM View: | Gunzburg Janet Principal Accounting Officer | Phreesia, Inc. (PHR) | 18-Apr-24 | Sale | 912 | $22.85 | $20,836.50 | (3%) 36.13K to 35.22K |
